Russian Scientists Uncover Potential Treatment for Tick-Borne Encephalitis
In a significant breakthrough, Russian scientists have identified plant materials that may pave the way for a new drug to combat tick-borne encephalitis. This discovery, made from the plant Terminalia chebula, known for its use in Asian folk medicine, showcases promising anti-viral capabilities. Maxim Khasnatinov, a senior researcher at the Russian Scientific Center for Family Health in Irkutsk, emphasized the importance of this finding in developing new treatments for encephalitis and meningitis.
Khasnatinov stated, "As part of our studies to develop new chemical drugs for treating tick-borne encephalitis, we discovered substances in Terminalia chebula that have antiviral properties." The research team has already patented their discovery and is preparing to initiate preclinical trials for the new drugs. This is particularly crucial as the only current treatment option, donated immunoglobulin, has significant side effects and requires stringent storage conditions between 4 to 8 degrees Celsius.
The urgency of this research is underscored by recent statistics from the Epidemiological Surveillance Department in Irkutsk, which reported that approximately 15,400 individuals sought medical assistance this year following tick bites, reflecting a 22% increase compared to the previous year.
